You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

REZIPRES Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Rezipres, and what generic alternatives are available?

Rezipres is a drug marketed by Dr Reddys Labs Sa and is included in one NDA.

The generic ingredient in REZIPRES is ephedrine hydrochloride. There are sixty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ephedrine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for REZIPRES?
  • What are the global sales for REZIPRES?
  • What is Average Wholesale Price for REZIPRES?
Summary for REZIPRES
Drug patent expirations by year for REZIPRES
Drug Prices for REZIPRES

See drug prices for REZIPRES

US Patents and Regulatory Information for REZIPRES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Sa REZIPRES ephedrine hydrochloride SOLUTION;INTRAVENOUS 213536-001 Jun 14, 2021 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys Labs Sa REZIPRES ephedrine hydrochloride SOLUTION;INTRAVENOUS 213536-004 Dec 7, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys Labs Sa REZIPRES ephedrine hydrochloride SOLUTION;INTRAVENOUS 213536-002 Jun 14, 2021 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.